Performing the first transcatheter tricuspid valve replacement at ChristianaCare. (Photo courtesy ChristianaCare)
WILMINGTON—ChristianaCare has become the first health system in Delaware to offer two new FDA-approved, minimally invasive procedures for patients with tricuspid valve disease.
These groundbreaking treatments, TriClip and EVOQUE, can repair or replace a failing tricuspid valve without open-heart surgery, giving patients a safer option and faster recovery.
New options for tricuspid valve regurgitation
The tricuspid valve directs blood flow through the heart, but when it fails to close properly, blood leaks backward — a condition known as tricuspid valve regurgitation. This forces the heart to work harder, often leading to fatigue, shortness of breath, and swelling…